Kessler Foundation researchers published results of their TBI-MEM trial, the first study to demonstrate significant changes in cerebral activation after memory retraining in individuals with traumatic brain injury (TBI). The article was published by the Journal of Head Trauma Rehabilitation. The authors are Nancy Chiaravalloti, Ekaterina Dobryakova, Glenn Wylie and John DeLuca, of Kessler Foundation.
In just two years, people with type 2 diabetes experienced negative changes in their ability to regulate blood flow in the brain, which was associated with lower scores on tests of cognition skills and their ability to perform their daily activities, according to a new study published in the 8 July, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.
After comparing more than 20,000 brain scans, researchers have identified differences between traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD) despite both conditions sharing common symptoms.
An optical technology already widely used in ophthalmology and other medical fields holds potential to reveal how blood flows in the brain during stroke, providing information that could someday guide new treatments and reduce stroke-induced damage to the brain.
A new map of emergency stroke care in the USA illustrates the patchwork system in place for delivering the most effective treatment. In the journal Stroke, University of Michigan Medical School researchers report the results of a study that for the first time shows wide geographic variation in use of “clotbuster” treatments for stroke.
For the first time, the American Heart Association/American Stroke Association recommends using a stent retrieval device to remove blood clots in select stroke patients who have clots obstructing the large arteries supplying blood to the brain, according to a new focused update published in the American Heart Association journal Stroke.
Neuravi has completed a Series B financing of €19m (US$21m) to advance the company’s minimally invasive thrombectomy device for acute ischaemic stroke, the EmboTrap revascularization device. The round was led by European private equity firm Life Sciences Partners (LSP), with participation from returning Series A investors Fountain Healthcare Partners, Delta Partners and the Western Development Commission.
National Institutes of Health director Francis S Collins has announced the selection of Walter J Koroshetz, as the Director of the National Institute of Neurological Disorders and Stroke (NINDS). He has served as acting director of the NINDS since October 2014.
Elekta has CE marked its Leksell Gamma Knife Icon precision radiosurgery system, making this latest generation Leksell Gamma Knife platform available in the European market.
Major advancements in stroke treatment occurred this year: the standard of care has changed and we are now faced with the challenge to modify the chain of survival of stroke patients. Stroke patients have to reach comprehensive stroke centres (CSC) particularly if they are suspect to have an acute large vessel occlusion. This commentary presents the top 10 reasons why comprehensive stroke centres should become patient destination.
In a Policy View published in The Lancet Neurology journal, a group of leading experts on the epidemiology of dementia state that the number of people with dementia—both new cases and total numbers with the disease—in some Western European countries is stabilising despite population ageing, in direct contrast to the “dementia epidemic” reported in some recent studies.
A new study finds that Cefaly, the first US Food and Drug Administration (FDA)-approved transcutaneous electrical nerve stimulation device specifically authorised for use prior to the onset of migraine pain, provides relief for 81% of migraine sufferers who use it.
BrainStorm Cell Therapeutics has completed enrolment in its ongoing randomised, double-blind placebo-controlled phase 2 clinical trial of NurOwn in amyotrophic lateral sclerosis (ALS). The targeted enrolment of 48 subjects has been achieved.
Five men with complete motor paralysis were able to voluntarily generate step-like movements thanks to a new strategy that non-invasively delivers electrical stimulation to their spinal cords, according to a new study funded in part by the National Institutes of Health (NIH).
Advice to use the anti-clotting drug alteplase more than three hours after an acute stroke should be re-evaluated, say researchers writing in The BMJ this week.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos